Canadian Biotech Leader Clarissa Desjardins Secures $63 Million CAD For Congruence Therapeutics By congruence1|2023-01-29T09:12:41-08:0002.08.2022|News|0 Comments Read More
Montreal biotech startup Congruence raises $50-million to focus on rare disease drugs By congruence1|2023-01-29T09:13:55-08:0002.08.2022|News|0 Comments Read More
Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding By congruence1|2023-01-29T09:17:01-08:0002.08.2022|News|0 Comments Read More
